Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-31T21:36:08.673Z Has data issue: false hasContentIssue false

Introduction

Published online by Cambridge University Press:  03 May 2024

Stephen M. Stahl
Edited in association with
Jeffrey R. Strawn
Stephen M. Stahl
Affiliation:
University of California, San Diego
Jeffrey R. Strawn
Affiliation:
University of Cincinnati, Ohio
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Prescriber's Guide – Children and Adolescents
Stahl's Essential Psychopharmacology
 , pp. vii - xviii
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aldrich, SL, Poweleit, EA, Prows, CA et al. Influence of CYP2C19 metabolizer status on escitalopram/citalopram tolerability and response in youth with anxiety and depressive disorders. Front Pharmacol 2019;10(February):99; doi:10.3389/fphar.2019.00099.CrossRefGoogle ScholarPubMed
Bousman, CA, Stevenson, JM, Ramsey, LB, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther. 2023;114(1):51–68. doi:10.1002/cpt.2903.CrossRefGoogle ScholarPubMed
Cardoso, TDA, Jansen, K, Zeni, CP et al. Clinical outcomes in children and adolescents with bipolar disorder and substance use disorder comorbidity. J Clin Psychiatry 2017;78(3):e230–e233; doi:10.4088/JCP.15m10293.CrossRefGoogle ScholarPubMed
Correll, CU, Sheridan, EM, DelBello, MP. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord 2010;12(2):116–41; doi:10.1111/j.1399-5618.2010.00798.x.CrossRefGoogle Scholar
Dobson, ET, Bloch, MH, Strawn, JR. Efficacy and tolerability of pharmacotherapy for pediatric anxiety disorders: a network meta-analysis. J Clin Psychiatry 2019;80(1):17r12064; doi:10.4088/JCP.17r12064.CrossRefGoogle ScholarPubMed
Findling, RL, Kafantaris, V, Pavuluri, M et al. Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 2011;21(3):195–205; doi:10.1089/cap.2010.0084.CrossRefGoogle ScholarPubMed
Ghuman, JK, Riddle, MA, Vitiello, B et al. Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol 2007;17(5):563–80; doi:10.1089/cap.2007.0071.CrossRefGoogle ScholarPubMed
Keeshin, BR, Monson, E. Assessing and responding to the trauma of child management. Focus 2022;20(2):176–83; doi:10.1176/appl.focus.20210033.Google Scholar
Koch, MT, Carlson, HE, Kazimi, MM et al. Antipsychotic-related prolactin levels and sexual dysfunction in mentally ill youth: a 3-month cohort-study. J Am Acad Child Adolesc Psychiatry 2023;62(9):1021–50; doi:10.106/j.jaac.2023.0.007.CrossRefGoogle ScholarPubMed
Luft, MJ, Lamy, M, DelBello, M et al. Antidepressant-induced activation in children and adolescents: risk, recognition and management. Curr Probl Pediatr Adolesc Health Care 2018;48(2):50–62; doi:10.1016/j.cppeds.2017.12.001.CrossRefGoogle Scholar
Maayan, L, Correll, CU. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 2011;21(6):517–35; doi:10.1089/cap.2011.0015.CrossRefGoogle ScholarPubMed
Masi, G, Perugi, G, Toni, C et al. Obsessive-compulsive bipolar comorbidity: focus on children and adolescents. J Affect Disord 2004;78(3):175–83; doi: 10.1016/S0165-0327(03)00107-1.CrossRefGoogle ScholarPubMed
Masi, G, Perugi, G, Toni, C et al. Attention-deficit hyperactivity disorder – bipolar comorbidity in children and adolescents. Bipolar Disord 2006;8(4):373–81; doi:10.1111/j.1399-5618.2006.00342.x.CrossRefGoogle ScholarPubMed
Ramsey, LB, Bishop, JR and Strawn, JR. Pharmacogenetics of treating pediatric anxiety and depression. Pharmacogenomics 2019;20(12):867–70; doi:10.2217/pgs-2019-0088.CrossRefGoogle ScholarPubMed
Ramsey, LB, Namerow, LB, Bishop, JR et al. Thoughtful clinical use of pharmacogenetics in child and adolescent psychopharmacology. J Am Acad Child Adolesc Psychiatry 2020;60(6):660–4; doi:10.1016/j.jaac.2020.08.006.Google ScholarPubMed
Sakolsky, DJ, Perel, JM, Emslie, GJ et al. Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study. J Clin Psychopharmacol 2011;31(1):92–7; doi:10.1097/JCP.0b013e318204b117.CrossRefGoogle ScholarPubMed
Strawn, JR, Mills, JA, Poweleit, EA, Ramsey, LB, Croarkin, PE. Adverse effects of antidepressant medications and their management in children and adolescents. Pharmacotherapy 2023;43(7):675–90; doi:1002/phar.2767.CrossRefGoogle ScholarPubMed
Strawn, JR, Mills, JA, Schroeder, H et al. Escitalopram in adolescents with generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychiatry 2020;81(5):20m13396; doi:10.4088/JCP.20m13396.CrossRefGoogle ScholarPubMed
Strawn, JR, Poweleit, EA, Ramsey, LB. CYP2C19-guided escitalopram and sertraline dosing in pediatric patients: a pharmacokinetic modeling study. J Child Adolesc Psychopharmacol 2019;29(5):340–7; doi:10.1089/cap.2018.0160.CrossRefGoogle ScholarPubMed
Strawn, JR, Ramsey, LB. Chapter 53.5. Pediatric psychopharmacology. In Kaplan and Sadock’s Comprehensive Textbook of Psychiatry. 11th ed. Philadelphia: Lippincott Williams & Wilkins, 2024; 50–60.Google Scholar
Strawn, JR, Ramsey, LB, Croarkin, PE. Pharmacogenetic testing and antidepressants in youth with depressive and anxiety disorders. J Am Acad Child Adolesc Psychiatry 2018;57(10); doi:10.1016/j.jaac.2018.07.733.CrossRefGoogle Scholar
Strawn, JR, Vaughn, S, Ramsey, LB. Pediatric psychopharmacology for depressive and anxiety disorders. Focus (Madison) 2022;20(2):184–90; doi:10.1176/appi.focus.20210036.Google ScholarPubMed
Vaughn, SE, Strawn, JR, Poweleit, EA et al. The impact of marijuana on antidepressant treatment in adolescents: clinical and pharmacologic considerations. J Pers Med 2021;11(7):615; doi:10.3390/jpm11070615.CrossRefGoogle ScholarPubMed
Weinberger, AH, Zhu, J, Lee, J et al. Cannabis use among youth in the United States, 2004–2016: faster rate of increase among youth with depression. Drug Alcohol Depend 2020; 209:107894; doi:10.1016/j.drugalcdep.2020.107894.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Introduction
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Introduction
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Introduction
  • Stephen M. Stahl, University of California, San Diego
  • Edited in association with Jeffrey R. Strawn, University of Cincinnati, Ohio
  • Book: Prescriber's Guide – Children and Adolescents
  • Online publication: 03 May 2024
Available formats
×